State Council joint defense joint control mechanism: every vaccine source in my country can be chased, and the whereabouts can be checked

Zhongxin Jingwei, July 23rd, on the 23rd, the State Council's joint prevention and control mechanism held a press conference on the relevant situation of the safety effectiveness of the new coronary virus vaccine. Including the establishment of an independent operation of the new crown vaccine information traceability regulatory system to ensure that each vaccine source can be chased and the whereabouts can be checked.

New crown vaccine vaccination rate reached 89.7%

At the meeting, regarding the vaccination of vaccination, the deputy director of the National Health Commission, the head of the research and development of the research and development of the research and development group of the State Council ’s joint prevention and control mechanism, and Zeng Yixin, an academician of the Chinese Academy of Sciences. As of July 22, 31 provinces (cities, districts) The cumulative report of the Xinjiang Production and Construction Corps reported a total of 341.6727 million doses of the new crown vaccine, the total number of vaccinations reached 129.8636 million, and the first dose was vaccinated by 92.1%. The completion of 797.985 million inocular vaccination was completed, and the immune vaccination rate was 71.7%. In general, the vaccination rate is relatively high.

In terms of vaccination for the elderly, Zeng Yixin said that at present, at least 1 dose of vaccination in my country is 89.6%, the basic immunization vaccination ratio has reached 84.7%, and the immunization vaccination rate has reached 67.3%. However, there is still room for improvement, mainly two problems: one is that the vaccination coverage of elderly people over 80 years of age needs to be improved; the second is that the enhanced needle vaccination rate of the elderly needs to be improved.

Specifically, at least 1 dose of vaccination rate of at least 1 dose of 60-69 years old is 91.8%, the basic immunization rate is 89.1%; at least 1 dose of vaccination rate of at least 1 dose of 70-79 years old is 92.7%, and the basic immunization rate is 87.1%. ; The vaccination rate of at least 1 dose of people over 80 years of age reaches 73.5%, and the basic immunization rate is 61%. The enhanced needle vaccination of the elderly is: the enhanced immunization rate of 60-69 years old is 72.8%; the enhanced immune vaccination rate of 70-79 years old is 69.9%; the enhanced immune vaccination rate for people over 80 years old is 38.4%.

Zeng Yixin pointed out that, whether it is domestic or overseas data, because the proportion of basic diseases in the elderly is relatively high, once the new crown virus is infected, whether it is an early strain or the popular Omircor strains now, severe illnessed and The risk of death is high. In addition, the elderly people are different from young people. The immune function of the elderly is relatively weak. It needs to be used to enhance the needle to obtain the best protection effect. Therefore, sincerely calling on everyone to help the elderly, help them solve their doubts, provide them with convenience of vaccination, and strive to further improve the new crown vaccination rate of the elderly in a relatively short period of time.

The source of the vaccine can be chased, the whereabouts can be checked

Regarding the problems of vaccine quality and safety, Wang Junzhi, the deputy leader of the Expert Group of the State Health and Health Commission's research and development of the research and development of the Scientific Research and Development Class of the National Health and Health Commission, introduced that after being approved by my country's vaccine listing, there is actually a complete set of regulatory processes to ensure the vaccine of the vaccine. quality.

Wang Junzhi said that first of all, before each vaccine was leaving the factory, the enterprise must be tested in accordance with the national approval standards. The following important steps, the national legal inspection agencies need to be approved and issued on the vaccine, and the legal inspection agencies are required to inspect and review each batch of vaccines that are about to be listed. In this process, they are inspected in accordance with national approval standards. The inspection report is issued after the inspection is qualified to meet the standard, allowing release.

In addition, Wang Junzhi pointed out that after the vaccine finished product was released, there was a series of measures to ensure the quality of the vaccine during the use process. For example, the production line expansion work process and technical guidelines have been introduced, and an independent operation of the new crown vaccine information traceability regulatory system is established to ensure that each vaccine source can be chased and the direction can be checked. Through the above series of measures, the safety and reliability of the new crown vaccine listed on the market is ensured. (Zhongxin Jingwei APP)

Pay attention to the official WeChat public account of JWVIEW (JWVIEW) to get more elite financial information.

- END -